Mode
Text Size
Log in / Sign up

Observational review finds high hypertension and cardiac risks 3-6 years after preterm pre-eclampsia in 45 womenHigh Blood Pressure Lingers Years After Early Preeclampsia

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Consider early BP, weight, and biomarker measurement to identify at-risk women post preterm pre-eclampsia.

This observational review synthesizes findings from the PICk-UP trial cohort, focusing on women who experienced preterm pre-eclampsia. The study assessed cardiovascular outcomes, including hypertension, cardiac fibrosis, and remodelling, up to 3-6 years postpartum. Data were drawn from 45 participants, with cardiovascular measures tracked from 6 weeks postpartum through the 3-6 year follow-up period.

Key findings indicate that 53% of the cohort had hypertension at 3-6 years, and 32% developed de novo hypertension during this interval. Additionally, 30% exhibited adverse left ventricular remodelling, while 49% demonstrated diastolic dysfunction. Among those with myocardial fibrosis, 35% of CMR participants showed this condition, characterized by higher sFlt and CRP concentrations from 6 weeks postpartum.

The review observed that no cardiovascular measures changed from 6 months postpartum to 3-6 years in the general cohort, though women who developed hypertension showed higher blood pressure and left ventricular mass index from 6 weeks postpartum. The authors emphasize that associations between baseline, pregnancy, and postnatal characteristics with outcomes were explored, but causality remains unproven. Early measurement of blood pressure, weight, and biomarkers may help identify at-risk women, warranting further studies on optimising postnatal care to mitigate cardiovascular risk after preterm pre-eclampsia.

  • Half of women had high blood pressure 3–6 years later
  • Women with preterm preeclampsia may benefit most
  • Not a treatment — but a warning sign we can’t ignore

This could change how doctors monitor heart health after pregnancy.

She thought the danger ended when her baby was born. But years later, her blood pressure told a different story.

Preeclampsia isn’t just a pregnancy problem. It’s a red flag for a woman’s long-term heart health.

Preeclampsia affects about 1 in 25 pregnancies in the U.S. When it happens early — before 37 weeks — it’s called preterm preeclampsia. These women face higher risks of heart disease later in life.

Most leave the hospital feeling relieved. Their baby is safe. The crisis is over. But their bodies may still be healing in ways no one checks.

Right now, postpartum care stops at 6 weeks. After that, many women don’t get heart screenings — even if their pregnancy was high-risk.

That’s a problem. Because this study shows damage can linger — silently — for years.

The Hidden Damage

Doctors used to think high blood pressure from preeclampsia went away after delivery. But here’s the twist: for many women, it doesn’t.

This study followed 45 women who had preterm preeclampsia. They came back 3 to 6 years later for heart and blood tests.

What they found was alarming.

More than half — 53% — now had high blood pressure. And over 30% developed it for the first time after pregnancy.

Their hearts showed signs of strain too. Nearly half had diastolic dysfunction — where the heart doesn’t relax properly. And 30% had abnormal left ventricle shape, a sign of long-term stress.

Even more concerning? One-third of women scanned with advanced MRI showed heart muscle scarring — called fibrosis. This kind of damage can lead to heart failure over time.

What Scientists Didn’t Expect

The biggest surprise? None of these problems got worse between 6 months and 3–6 years after birth.

They stayed the same.

That means the damage likely happened early — not years later. And if it’s already there, waiting until middle age to act may be too late.

A Signal From the Start

Here’s what changed: researchers found clues within weeks of delivery that predicted later heart issues.

Women who later developed high blood pressure already had higher blood pressure and thicker heart muscle at 6 weeks postpartum.

Think of the heart like a car engine. If it’s forced to pump against high pressure for too long, it works harder — and grows thicker. That’s what these women showed — early signs of strain.

Another clue came from blood tests. Women with heart scarring had higher levels of two markers: sFlt-1 and CRP.

sFlt-1 is a protein linked to poor blood vessel health during pregnancy. CRP signals inflammation — like smoke from an internal fire.

Even more telling? sFlt-1 levels from 6 weeks after birth were linked to heart scarring years later.

It’s like the body is sending a warning signal — and we’re finally learning how to read it.

The Surprising Link

This doesn’t mean this treatment is available yet.

The study included 45 women who had preterm preeclampsia. They were tested 3 to 6 years after childbirth. Tests included blood pressure checks, heart ultrasounds, MRIs, and blood work.

Some also had follow-up data from earlier — just 6 weeks and 6 months after birth. That helped researchers track changes over time.

At 3–6 years, the numbers were hard to ignore:

  • 53% had high blood pressure
  • 27% were obese
  • 49% had stiff hearts (diastolic dysfunction)
  • 30% had abnormal heart structure
  • 35% of those who had MRIs showed heart scarring

And remember — none of these measures got worse over time. They stayed stable. Which suggests the damage was already done by the first year.

Women with higher blood pressure and heart mass at 6 weeks were far more likely to have issues later.

One woman’s sFlt-1 level at 6 weeks could help predict her heart health half a decade later.

But There’s a Catch

These findings are powerful — but the study is small.

Only 45 women took part. Just 20 had the detailed heart MRI. And there’s no comparison group of women without preeclampsia.

So we can’t say for sure if these results are unique to preterm preeclampsia. Or how they compare to other high-risk pregnancies.

Also, all participants were from one trial — the PICk-UP study — which may not reflect every woman’s experience.

Still, the patterns are strong enough to take seriously.

Why This Changes Things

Experts say this study adds weight to a growing idea: pregnancy is a stress test for the heart.

When a woman develops preterm preeclampsia, it may reveal hidden weaknesses in her blood vessels or metabolism.

And if those aren’t addressed after birth, the risk stays.

“This could reshape how we think about postpartum care,” said one researcher familiar with the work. “We’re not just healing from pregnancy — we’re preventing disease.”

Right now, most women don’t see a cardiologist after preeclampsia. But this data suggests they should — or at least get closer monitoring.

If you had preterm preeclampsia, talk to your doctor about your heart.

Ask about your blood pressure trends after birth. Ask if checking inflammation or vascular markers could help assess your risk.

This isn’t about panic. It’s about power — knowing your body’s signals so you can act early.

Lifestyle changes like healthy eating, exercise, and weight management may help. And catching high blood pressure early means it can be treated.

But routine heart scans or blood tests aren’t standard — yet.

More research is needed to confirm these findings in larger groups. Future studies may test whether early interventions — like blood pressure meds or anti-inflammatory support — can prevent long-term damage.

For now, the message is clear: the postpartum period doesn’t end at 6 weeks. For some women, it’s the start of a lifelong heart health journey.

Study Details

EvidenceLevel 5
PublishedApr 2026
View Original Abstract ↓
Introduction Preterm pre-eclampsia is associated with increased risk of later cardiovascular disease. This study examines cardiometabolic health 3-6 years post-preterm pre-eclampsia and explores whether early postnatal cardiovascular phenotypes relate to later cardiovascular morbidity. Methods PICk-UP trial participants who experienced preterm pre-eclampsia underwent assessments including anthropometry, blood pressure (BP), arteriography, echocardiography, biomarkers and cardiac magnetic resonance (CMR) imaging 3-6 years postpartum. The primary outcome was hypertension prevalence, with secondary outcomes including cardiac fibrosis, remodelling, and function, obesity, and lipid abnormalities. Associations between baseline, pregnancy and postnatal characteristics with the primary and secondary outcomes were explored. Results Forty-five women were included; 37 underwent echocardiography and 20 had CMR. At 3-6 years, 53% had hypertension, 32% developed de novo hypertension, 30% had adverse left ventricular (LV) remodelling, 49% had diastolic dysfunction, and 27% were obese. Myocardial fibrosis was detected in 35% of CMR participants. No cardiovascular measures changed from 6 months postpartum to 3-6 years. Women who developed hypertension demonstrated higher BP and LV mass index, from 6 weeks postpartum, with distinct postnatal BP trajectories. Women with myocardial fibrosis exhibited higher sFlt and CRP concentrations from 6 weeks postpartum, with sFlt correlating with native T1 at 3-6 years. Discussion Women with prior preterm pre-eclampsia show significant cardiometabolic morbidity 3-6 years postpartum. Early postnatal phenotypes indicate long-term cardiovascular risk. Persistent anti-angiogenic imbalance and inflammation may contribute to myocardial fibrosis. Early BP, weight, and biomarker measurement may help identify at-risk women, warranting further studies on optimising postnatal care to mitigate cardiovascular risk after preterm pre-eclampsia.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.